Rituximab in IgG4-related Disease: A Phase 1-2 Trial

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the safety and effectiveness of rituximab in IgG4-RD.

Clinical Trial Description

This two-center trial will enroll at total of 30 patients with IgG4-RD. The two participating sites are the Massachusetts General Hospital (Boston, MA) and the Mayo Clinic (Rochester, MN). All patients will receive rituximab 1 gram intravenously times two doses, separated by approximately 15 days. The primary efficacy outcome - disease remission and successful completion of the glucocorticoid taper - will be assessed at six months. Patients will be followed on the protocol for an additional six months after measurement of the primary outcome. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01584388
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	April 2012
Completion date	January 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03753815` - Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune Pancreatitis	N/A
Recruiting	`NCT02797665` - Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids	N/A
Recruiting	`NCT04834505` - To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
Recruiting	`NCT04397731` - Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune Pancreatitis
Not yet recruiting	`NCT06358001` - EchoTip AcuCore Post-Market Clinical Study
Completed	`NCT05476978` - Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
Recruiting	`NCT06369909` - Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
Recruiting	`NCT01774513` - EUS-guided Procore-biopsy in Diagnosing Autoimmune Pancreatitis	N/A
Completed	`NCT03241797` - Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis	N/A
Completed	`NCT05171517` - Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
Withdrawn	`NCT01845467` - Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
Completed	`NCT05565066` - A Real-world Comparison of FNB and FNA in IHC-required Lesions.
Completed	`NCT02705638` - Treatment of IgG4-Related Disease With Revlimid and Rituximab	Phase 1
Withdrawn	`NCT02766842` - Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)	Phase 2
Completed	`NCT00588367` - CT Pancreas Perfusion	N/A